A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
about
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
description
scientific article published on 01 December 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
A RAD51 assay feasible in rout ...... response beyond BRCA mutation
@en
A RAD51 assay feasible in rout ...... response beyond BRCA mutation
@nl
type
label
A RAD51 assay feasible in rout ...... response beyond BRCA mutation
@en
A RAD51 assay feasible in rout ...... response beyond BRCA mutation
@nl
prefLabel
A RAD51 assay feasible in rout ...... response beyond BRCA mutation
@en
A RAD51 assay feasible in rout ...... response beyond BRCA mutation
@nl
P2093
P50
P356
P1476
A RAD51 assay feasible in rout ...... response beyond BRCA mutation
@en
P2093
Alejandra Bruna
Alejandro Moles-Fernández
Benedetta Pellegrino
Cristina Cruz
Cristina Saura
Cristina Viaplana
Guillermo Villacampa
Isabel T Rubio
J Carl Barrett
Jacques Simard
P356
10.15252/EMMM.201809172
P407
P50
P577
2018-12-01T00:00:00Z